Products - Headaches | Topic | NICE

Showing 5 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

STS101 for treating acute migraine TS ID 11782
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Galcanezumab for migraine TS ID 10663
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Upadacitinib for treating giant cell arteritis [ID6299]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Botulinum toxin type A for preventing episodic migraine ID 6450
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Zavegepant for treating acute migraine TSID 11998
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC